Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lefamulin for Mycoplasma Genitalium Treatment Failures
NCT05111002Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Apr 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lefamulin in Mycoplasma genitalium infection (Mgen), sponsored by University of Washington. Started Apr 2022; status: terminated.
02
Drugs
lefamulin
03
Conditions
Mycoplasma genitalium infection (Mgen)
Beyond the preview
Go deeper on NCT05111002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05111002.